Faldaprevir
An investigational anti-hepatitis C virus drug.
General information
Faldaprevir on PubChem
CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)O[C@@H]4C[C@H](N(C4)C(=O)[C@H](C(C)(C)C)NC(=O)OC5CCCC5)C(=O)N[C@@]6(C[C@H]6C=C)C(=O)O
Supporting references
| Link | Tested on | Impact factor | Notes | Publication date |
|---|---|---|---|---|
|
Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation
3CLpro Small molecule In silico |
in silico | 4.00 | Predicted to inhibit the SARS-CoV-2 3C-like protease. |
Oct/19/2020 |